Innovative CEA Testing Technologies and Emerging MarketsReport Details:Published:November 2012No. of Pages: 250Price: Single User License – US$3850Presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy,Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and marketshares for major suppliers. The cancer diagnostics market is on the verge of explosion, as theresearchers approach major technological breakthroughs in tumor diagnosis and therapy, discovernew specific antigens, and unlock the mystery of the genetic basis of the disease. During the nextten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidlyexpanding field. Anticipated technological breakthroughs will create numerous opportunities fordetermining genetic predisposition, detecting specific tumors, and monitoring biological responseto cancer therapy. The rise in geriatric population will further compound the growing demand formalignancy assays and the rapid market expansion worldwide.The report also examines marketapplications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT,chromosome analysis, and other technologies; reviews features and operating characteristics ofautomated analyzers; profiles leading suppliers and recent market entrants developing innovativetechnologies and products; and identifies alternative market penetration strategies and entrybarriers/risks.Get your copy of this report @http://www.reportsnreports.com/reports/207481-innovative-cea-testing-technologies-and-emerging-markets.htmlMajor points covered in Table of Contents of this report includeTable of ContentsI. IntroductionII. CEA Worldwide Market and Technology OverviewA. Carcinoembrionic Antigen (CEA): Clinical Significanceand Laboratory PracticesB. Instrumentation Review AndMarket Needs1. Abbott AxSYM
E. Personal TestingIII. France: Market Size, Growth and Major Suppliers’Sales and Market SharesIV. Germany: Market Size, Growth and Major Suppliers’Sales and Market SharesV. Italy: Market Size, Growth and Major Suppliers’Sales and Market SharesVI. Japan: Market Size, Growth and Major Suppliers’Sales and Market SharesVII. Spain: Market Size, Growth and Major Suppliers’Sales and Market SharesVIII. U.K.: Market Size, Growth and Major Suppliers’Sales and Market SharesIX. U.S.A.: Market Size, Growth and Major Suppliers’Sales and Market SharesX. Design Criteria for Decentralized Testing ProductsXI. Alternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market Segmentation FactorXII. Potential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. Competition
PolymedcoPreMDQiagenRadient PharmaceuticalsRocheScienionSequenomSiemens HealthcareTakara BioTargeted Diagnostics & TherapeuticsTosohVeridexWako Pure ChemicalsWallac/PEZilaList of TablesMajor Companies Developing or Marketing CEA TestsFranceCEA Test Volume and Diagnostics Sales by Market SegmentFranceCEA Testing Market by Major SupplierGermanyCEA Test Volume and Diagnostics Sales by Market SegmentGermanyCEA Testing Market by Major SupplierItalyCEA Test Volume and Diagnostics Sales by Market SegmentItalyCEA Testing Market by Major SupplierJapanCEA Test Volume and Diagnostics Sales by Market SegmentJapanCEA Testing Market by Major SupplierSpainCEA Test Volume and Diagnostics Sales by Market SegmentSpainCEA Testing Market by Major SupplierU.K.CEA Test Volume and Diagnostics Sales by Market SegmentU.K.
CEA Testing Market by Major SupplierU.S.A.CEA Test Volume and Diagnostics Sales by Market SegmentU.S.A.CEA Testing Market by Major SupplierContact: email@example.com for more information.